The economic impact of heartwater on the South African livestock industry and the need for a new vaccine.


Journal

Preventive veterinary medicine
ISSN: 1873-1716
Titre abrégé: Prev Vet Med
Pays: Netherlands
ID NLM: 8217463

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 22 10 2021
revised: 16 03 2022
accepted: 25 03 2022
pubmed: 4 4 2022
medline: 18 5 2022
entrez: 3 4 2022
Statut: ppublish

Résumé

Heartwater is a dangerous tick-borne disease for livestock farmers in South Africa and results in annual economic losses for the livestock industry. This study determined the total economic impact of heartwater in South Africa by calculating this disease's direct and indirect costs. Survey data from 272 livestock farmers from six provinces of South Africa was used for this study. Available heartwater research in South Africa only focused on the prevention and control of and vaccination against heartwater, with no research having undertaken an in-depth study of the total economic impact of this disease. The highest cost due to heartwater at provincial level was calculated for the Eastern Cape Province, followed by the North West and Mpumalanga Provinces. Heartwater has an enormous impact on the cattle industry, with an approximate R1 059 million losses experienced each year. The sheep industry experiences a total cost loss of approximately R168 million per year, with the goat industry experiencing about R39 million per year. The total economic impact of heartwater on the South African livestock industry is estimated at R1 266 million per annum. The direct cost contributed 66.47%, and indirect costs contributed 33.57% to the total cost of heartwater. The annual cost of heartwater vaccines contributed the least to the total cost of heartwater, with only 10% of the participants administering the heartwater vaccine. A total of 84.29% of the respondents indicated a need for a new and improved heartwater vaccine. This study emphasises the importance of heartwater in South Africa and farmers' high costs because of this disease. If an improved heartwater vaccine can be developed, the direct cost of heartwater will reduce, which is the bulk of its economic impact. This research can serve as a basis for future research on heartwater, where cost-benefit analyses could be conducted on heartwater's different prevention and control methods.

Identifiants

pubmed: 35367935
pii: S0167-5877(22)00067-8
doi: 10.1016/j.prevetmed.2022.105634
pii:
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105634

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

M J J van den Heever (MJJ)

University of the Free State, Department of Agricultural Economics, P.O. Box 339, Internal box 58, Bloemfontein 9300, South Africa. Electronic address: VanDenHeeverMJJ@ufs.ac.za.

W A Lombard (WA)

University of the Free State, Department of Agricultural Economics, P.O. Box 339, Internal box 58, Bloemfontein 9300, South Africa. Electronic address: LombardWA@ufs.ac.za.

Y T Bahta (YT)

University of the Free State, Department of Agricultural Economics, P.O. Box 339, Internal box 58, Bloemfontein 9300, South Africa. Electronic address: Bahtay@ufs.ac.za.

F A Maré (FA)

University of the Free State, Department of Agricultural Economics, P.O. Box 339, Internal box 58, Bloemfontein 9300, South Africa. Electronic address: MareFA@ufs.ac.za.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH